Pharmacokinetic study of enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes. The PEPCI study

被引：0
|
作者：
Martin, JL
Fry, ETA
Serano, A
Atherley, TH
Ozoux, ML
Guimart, C
Chevalier, P
Bigonzi, F
Pensyl, C
Sanderink, GJ
机构：
[1] Care Grp, Indianapolis, IN USA
[2] Nasser Smith & Pinkerton Cardiol, Indianapolis, IN USA
[3] Aventis, Bridgewater, MA USA
[4] Newark Beth Israel Med Ctr, Newark, NJ USA
[5] Aventis, Paris, France
[6] BMH, Cardiac Cath Lab, Indianapolis, IN USA
来源：
EUROPEAN HEART JOURNAL | 2001年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic study of Enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes: The PEPCI study
    Martin, JL
    Fry, ET
    Sanderink, G
    Atherley, T
    Ozoux, ML
    Guimart, C
    Chevalier, P
    Pensyl, C
    Serano, A
    Bigonzi, F
    Sydney, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 10G - 11G
  • [2] Reliable anticoagulation with Enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study
    Martin, JL
    Fry, ETA
    Sanderink, GJCM
    Atherley, TH
    Guimart, CM
    Chevalier, PJ
    Ozoux, ML
    Pensyl, CE
    Bigonzi, F
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 61 (02) : 163 - 170
  • [3] The pharmacodynamics of enoxaparin in percutaneous coronary intervention with precise rapid enoxaparin loading (PEPCI-PRE study)
    Jack L. Martin
    Edward T. A. Fry
    Todd Martin
    Trevor H. Atherley
    Seth S. Martin
    Marvin J. Slepian
    [J]. Journal of Thrombosis and Thrombolysis, 2009, 28 : 224 - 228
  • [4] The pharmacodynamics of enoxaparin in percutaneous coronary intervention with precise rapid enoxaparin loading (PEPCI-PRE study)
    Jack L. Martin
    Edward T. A. Fry
    Todd Martin
    Trevor H. Atherley
    Seth S. Martin
    Marvin J. Slepian
    [J]. Journal of Thrombosis and Thrombolysis, 2009, 28 (2) : 229 - 229
  • [5] The pharmacodynamics of enoxaparin in percutaneous coronary intervention with precise rapid enoxaparin loading (PEPCI-PRE study)
    Martin, Jack L.
    Fry, Edward T. A.
    Martin, Todd
    Atherley, Trevor H.
    Martin, Seth S.
    Slepian, Marvin J.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 224 - 228
  • [6] Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes
    Collet, JP
    Montalescot, G
    Golmard, JL
    Tanguy, ML
    Ankri, A
    Choussat, R
    Beygui, F
    Drobinski, G
    Vignolles, N
    Thomas, D
    [J]. AMERICAN HEART JOURNAL, 2004, 147 (04) : 655 - 661
  • [7] Rapid attainment of reliable anti-xa levels with combined intravenous and subcutaneous enoxaparin in acute coronary syndromes; the PEPCI PRE study
    Martin, J
    Fry, E
    Sanderink, JG
    Atherley, TH
    Pensyl, C
    Mayhew, K
    Buszman, P
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 87 - 87
  • [8] Enoxaparin in acute coronary syndromes
    Lee, Sinjin
    Gibson, C. Michael
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2007, 5 (03) : 387 - 399
  • [9] Enoxaparin for acute coronary syndromes?
    Pechlaner, C
    Gritsch, W
    Wiedermann, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 2007 - 2007
  • [10] The "superiority" of enoxaparin for treatment of acute coronary syndromes
    Noviasky, JA
    Gaffney, BJ
    [J]. PHARMACOTHERAPY, 2001, 21 (10): : 1250 - 1252
12345